Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited reported a share repurchase on November 7, 2025, acquiring 195,600 H-shares on the Exchange. Prices for the repurchase ranged from HK$ 5.4 to HK$ 5.44, with an aggregate price paid of HK$ 1,060,528. This transaction increased the number of treasury shares by 195,600, bringing the total to 23,118,800.

Following the repurchase, the company's number of issued shares (excluding treasury shares) decreased by 195,600 to 4,499,213,524 from an opening balance of 4,499,409,124 on November 6, 2025. The repurchased shares represent 0.0043% of the existing issued shares (excluding treasury shares) before the event. The total number of issued shares remains unchanged at 4,522,332,324.

The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares. To date, 16,470,400 shares have been repurchased under this mandate, representing 3.6474% of the issued shares (excluding treasury shares) as at the date of the resolution. A moratorium period for new share issues or treasury share sales following this repurchase extends up to December 6, 2025.